Viral expression of constitutively active AKT3 induces CST axonal sprouting and regeneration, but also promotes

Thomas J Campion1, Imran S Sheikh2, Rupert D Smit1

  • 1Department of Neural Sciences, Lewis Katz School of Medicine, Temple University, 3500 North Broad Street, Philadelphia, PA 19140, United States of America; Shriners Hospitals Pediatric Research Center, Lewis Katz School of Medicine, Temple University, 3500 North Broad Street, Philadelphia, PA 19140, United States of America.

Experimental Neurology
|December 26, 2021
PubMed

Insights

Constitutively active Akt3 promotes axonal regeneration after injury but causes seizures and brain enlargement. STAT3 aids sprouting but not regeneration alone, though it synergizes with Akt3.

Area of Science:

  • Neuroscience
  • Regenerative Medicine
  • Molecular Biology

Background:

  • Enhancing intrinsic neuronal growth promotes axonal regeneration post-injury.
  • PI3K/AKT/mTOR and STAT3 pathways are key targets for promoting neural repair.

Purpose of the Study:

  • To investigate the effects of constitutively active Akt3 and STAT3 on corticospinal tract (CST) regeneration.
  • To evaluate the combined and individual impacts of caAkt3 and caSTAT3 on axonal regeneration and functional recovery.

Main Methods:

  • Cortical expression of constitutively active Akt3 and STAT3 in rodent models.
  • Assessment of CST axonal regeneration past the injury site.
  • Evaluation of functional recovery and histological changes, including seizures and hemimegalencephaly.

Main Results:

  • caAkt3 overexpression induced CST axonal regeneration independently of caSTAT3.
  • caSTAT3 enhanced axon sprouting and synergized with caAkt3 but did not promote regeneration alone.
  • Akt3 expression led to impressive axonal regeneration but no functional improvement, accompanied by seizures and hemimegalencephaly.

Conclusions:

  • Akt3 promotes axonal regeneration but causes detrimental side effects like seizures and brain enlargement.
  • STAT3 contributes to axonal sprouting and synergistic effects with Akt3, but is insufficient for regeneration as a monotherapy.
  • Targeting Akt3 for axonal regeneration requires careful consideration of its adverse effects.